Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study
- Author(s)
- Wang, M; Jurczak, W; Trneny, M; Belada, D; Wrobel, T; Ghosh, N; Keating, MM; van Meerten, T; Alvarez, RF; von Keudell, G; Thieblemont, C; Peyrade, F; Andre, M; Hoffmann, M; Szafer-Glusman, E; Lin, J; Dean, JP; Neuenburg, JK; Tam, CS;
- Details
- Publication Year 2026-08,Volume 209,Issue #2,Page 734-739
- Journal Title
- British Journal of Haematology
- Publication Type
- Research article
- Publisher
- Wiley
- Keywords
- ibrutinib; mantle cell lymphoma; venetoclax
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1111/bjh.70620
- Open Access at Publisher's Site
https://doi.org/10.1111/bjh.70620- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-08-06 02:27:27
Last Modified: 2026-09-16 04:38:39